417 related articles for article (PubMed ID: 33420940)
1. Tumor microenvironment promotes breast cancer chemoresistance.
Mehraj U; Dar AH; Wani NA; Mir MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):147-158. PubMed ID: 33420940
[TBL] [Abstract][Full Text] [Related]
2. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-mediated chemoresistance in breast cancer.
Velaei K; Samadi N; Barazvan B; Soleimani Rad J
Breast; 2016 Dec; 30():92-100. PubMed ID: 27668856
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cells and Targeting Strategies.
Barbato L; Bocchetti M; Di Biase A; Regad T
Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
[TBL] [Abstract][Full Text] [Related]
5. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
Madden EC; Gorman AM; Logue SE; Samali A
Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
[TBL] [Abstract][Full Text] [Related]
6. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
Das M; Law S
Int J Biochem Cell Biol; 2018 Oct; 103():115-124. PubMed ID: 30153480
[TBL] [Abstract][Full Text] [Related]
8. Breast tumor stroma: A driving force in the development of resistance to therapies.
Majidinia M; Yousefi B
Chem Biol Drug Des; 2017 Mar; 89(3):309-318. PubMed ID: 28042683
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.
Da Ros M; De Gregorio V; Iorio AL; Giunti L; Guidi M; de Martino M; Genitori L; Sardi I
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248992
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.
Bhavsar C; Momin M; Khan T; Omri A
Expert Opin Drug Deliv; 2018 Jul; 15(7):641-663. PubMed ID: 29301448
[TBL] [Abstract][Full Text] [Related]
12. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Weitzenfeld P; Meshel T; Ben-Baruch A
Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.
Plava J; Cihova M; Burikova M; Matuskova M; Kucerova L; Miklikova S
Mol Cancer; 2019 Mar; 18(1):67. PubMed ID: 30927930
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells.
Skolekova S; Matuskova M; Bohac M; Toro L; Durinikova E; Tyciakova S; Demkova L; Gursky J; Kucerova L
Cell Commun Signal; 2016 Jan; 14():4. PubMed ID: 26759169
[TBL] [Abstract][Full Text] [Related]
15. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
16. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Flipping from Foe to Friend: A Matter of Interest in Breast Carcinoma Heterogeneity Driving Drug Resistance.
Tandon I; Sharma NK
Curr Cancer Drug Targets; 2019; 19(3):189-198. PubMed ID: 29952260
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
Front Immunol; 2021; 12():799428. PubMed ID: 34992609
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
20. An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
Novohradsky V; Markova L; Kostrhunova H; Trávníček Z; Brabec V; Kasparkova J
Sci Rep; 2019 Sep; 9(1):13327. PubMed ID: 31527683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
